| Saham Orang Dalam | 73,232,600 shares |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.
Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.
Frekuensi Pembaruan: Setiap Hari
Skor Sentimen Petugas
Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.
Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.
Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.
Frekuensi Pembaruan: Setiap Hari
Metrik Utama Orang Dalam
Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.
Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).
Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)
N/A
Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).
Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)
N/A
Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.
Grafik Perdagangan Orang Dalam
Grafik berikut menunjukkan Epirus Biopharmaceuticals Inc transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.
Daftar Orang Dalam dan Metrik Profitabilitas
Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|
Report errors via our new Insider Auditing Tool
Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di EPRSQ / Epirus Biopharmaceuticals Inc. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di EPRSQ / Epirus Biopharmaceuticals Inc. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Riwayat Transaksi
Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.
| Berkas Tanggal |
Perdagangan Tanggal |
Formulir | Orang Dalam | Ticker | Judul Keamanan | Kode | Langsung | Latihan Harga |
Satuan Harga |
Unit Diubah |
Nilai Diubah (1 ribu) |
Sisa Pilihan |
Sisa Saham |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-05-31 | 2016-05-27 | 4 | Wyand Michael | EPRS | Restricted Stock Units | D | 280,000 | 280,000 | ||||||
| 2016-05-31 | 2016-05-27 | 4 | Shea Thomas A. | EPRS | Restricted Stock Units | D | 230,000 | 230,000 | ||||||
| 2016-05-31 | 2016-05-27 | 4 | Ticktin Robert | EPRS | Restricted Stock Units | D | 230,000 | 230,000 | ||||||
| 2016-05-31 | 2016-05-27 | 4 | Aurentz Vincent | EPRS | Restricted Stock Units | D | 230,000 | 230,000 | ||||||
| 2016-03-11 | 2016-02-27 | 4/A | Wyand Michael | EPRS | Common Stock | D | 2.8000 | -1,378 | -4 | 32,662 | ||||
| 2016-03-11 | 2016-02-27 | 4/A | Wyand Michael | EPRS | Common Stock | D | 2,608 | 34,040 | ||||||
| 2016-03-11 | 2016-02-27 | 4/A | Wyand Michael | EPRS | Common Stock | D | 1,044 | 31,432 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Wyand Michael | EPRS | Restricted Stock Units | D | -2,608 | 7,824 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Wyand Michael | EPRS | Restricted Stock Units | D | -1,044 | 0 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Wyand Michael | EPRS | Common Stock | D | 2.8000 | -1,379 | -4 | 32,661 | ||||
| 2016-03-01 | 2016-02-27 | 4 | Wyand Michael | EPRS | Common Stock | D | 2,608 | 34,040 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Wyand Michael | EPRS | Common Stock | D | 1,044 | 31,432 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Shea Thomas A. | EPRS | Restricted Stock Units | D | -3,073 | 9,217 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Shea Thomas A. | EPRS | Restricted Stock Units | D | -1,044 | 0 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Shea Thomas A. | EPRS | Common Stock | D | 2.8000 | -1,554 | -4 | 31,489 | ||||
| 2016-03-01 | 2016-02-27 | 4 | Shea Thomas A. | EPRS | Common Stock | D | 3,073 | 33,043 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Shea Thomas A. | EPRS | Common Stock | D | 1,044 | 29,970 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Munshi Amit | EPRS | Restricted Stock Units | I | -9,887 | 29,661 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Munshi Amit | EPRS | Restricted Stock Units | I | -1,519 | 0 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Munshi Amit | EPRS | Common Stock | I | 2.8000 | -4,305 | -12 | 177,083 | ||||
| 2016-03-01 | 2016-02-27 | 4 | Munshi Amit | EPRS | Common Stock | I | 9,887 | 181,388 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Munshi Amit | EPRS | Common Stock | I | 1,519 | 171,501 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Ticktin Robert | EPRS | Restricted Stock Units | D | -2,134 | 6,400 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Ticktin Robert | EPRS | Restricted Stock Units | D | -949 | 0 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Ticktin Robert | EPRS | Common Stock | D | 2,134 | 6,083 | ||||||
| 2016-03-01 | 2016-02-27 | 4 | Ticktin Robert | EPRS | Common Stock | D | 949 | 3,949 | ||||||
| 2015-12-22 | 2015-12-21 | 4 | Ticktin Robert | EPRS | Common Stock | D | 3.7205 | 3,000 | 11 | 3,000 | ||||
| 2015-12-21 | 2015-12-17 | 4 | Aurentz Vincent | EPRS | Common Stock | D | 3.4300 | 2,200 | 8 | 2,200 | ||||
| 2015-12-17 | 2015-12-16 | 4 | Munshi Amit | EPRS | Common Stock | I | 2.8000 | 8,270 | 23 | 169,982 | ||||
| 2015-12-16 | 2015-12-15 | 4 | Munshi Amit | EPRS | Common Stock | I | 2.8700 | 8,069 | 23 | 161,712 | ||||
| 2015-12-11 | 2015-12-09 | 4 | Aurentz Vincent Purchased by Spouse | EPRS | Common Stock | I | 3.8500 | 2,800 | 11 | 2,800 | ||||
| 2015-12-10 | 2015-12-09 | 4 | Munshi Amit | EPRS | Common Stock | I | 4.0700 | 13,190 | 54 | 153,643 | ||||
| 2015-11-10 | 2015-11-09 | 4 | Aurentz Vincent | EPRS | Non-Qualified Stock Option (Right to Buy) | D | 5.21 | 219,487 | 219,487 | |||||
| 2015-11-03 | 2015-11-03 | 4 | Shea Thomas A. | EPRS | Employee Stock Option (Right to Buy) | D | 1.30 | -28,926 | 20,662 | |||||
| 2015-11-03 | 2015-11-03 | 4 | Shea Thomas A. | EPRS | Common Stock | D | 1.3000 | 28,926 | 38 | 28,926 | ||||
| 2015-11-03 | 2015-11-02 | 4 | Ticktin Robert | EPRS | Employee Stock Option (Right to Buy) | D | 5.55 | 39,474 | 39,474 | |||||
| 2015-11-03 | 2015-11-02 | 4 | Shea Thomas A. | EPRS | Employee Stock Option (Right to Buy) | D | 5.55 | 56,842 | 56,842 | |||||
| 2015-11-03 | 2015-11-02 | 4 | Wyand Michael | EPRS | Employee Stock Option (Right to Buy) | D | 5.55 | 58,247 | 58,247 | |||||
| 2015-11-03 | 2015-11-02 | 4 | Munshi Amit | EPRS | Employee Stock Option (Right to Buy) | D | 5.55 | 199,537 | 199,537 | |||||
| 2015-09-22 | 2015-09-21 | 4 | Munshi Amit | EPRS | Common Stock | I | 6.1900 | 10,000 | 62 | 140,453 | ||||
| 2015-09-21 | 2015-09-18 | 4 | Munshi Amit | EPRS | Common Stock | I | 5.9860 | 10,000 | 60 | 130,453 | ||||
| 2015-09-14 | 2015-09-14 | 4 | Wyand Michael | EPRS | Employee Stock Option (Right to Buy) | D | 1.00 | -4,538 | 2,269 | |||||
| 2015-09-14 | 2015-09-14 | 4 | Wyand Michael | EPRS | Employee Stock Option (Right to Buy) | D | 1.00 | -4,209 | 3,880 | |||||
| 2015-09-14 | 2015-09-14 | 4 | Wyand Michael | EPRS | Common Stock | D | 1.0000 | 8,747 | 9 | 30,388 | ||||
| 2015-07-06 | 2015-07-02 | 4 | Munshi Amit | EPRS | Employee Stock Option (Right to Buy) | D | 1.00 | -22,681 | 14,860 | |||||
| 2015-07-06 | 2015-07-02 | 4 | Munshi Amit | EPRS | Employee Stock Option (Right to Buy) | D | 1.00 | -7,246 | 18,639 | |||||
| 2015-07-06 | 2015-07-02 | 4 | Munshi Amit | EPRS | Employee Stock Option (Right to Buy) | D | 1.00 | -21,273 | 43,397 | |||||
| 2015-07-06 | 2015-07-02 | 4 | Munshi Amit | EPRS | Common Stock | D | 1.0000 | 51,200 | 51 | 120,453 | ||||
| 2015-06-08 | 2015-06-05 | 4 | DUYK GEOFFREY M | EPRS | Non-Employee Stock Option (Right to Buy) | D | 6.39 | 9,000 | 9,000 | |||||
| 2015-06-08 | 2015-06-05 | 4 | BUCHI J KEVIN | EPRS | Non-Employee Stock Option (Right to Buy) | D | 6.39 | 9,000 | 9,000 | |||||
| 2015-06-08 | 2015-06-05 | 4 | ROCKLAGE SCOTT M | EPRS | Non-Employee Stock Option (Right to Buy) | D | 6.39 | 9,000 | 9,000 | |||||
| 2015-06-08 | 2015-06-05 | 4 | CORRIGAN MARK | EPRS | Non-Employee Stock Option (Right to Buy) | D | 6.39 | 9,000 | 9,000 | |||||
| 2015-06-08 | 2015-06-05 | 4 | Hunter William L | EPRS | Non-Employee Stock Option (Right to Buy) | D | 6.39 | 9,000 | 9,000 | |||||
| 2015-06-08 | 2015-06-05 | 4 | McHugh Julie | EPRS | Non-Employee Stock Option (Right to Buy) | D | 6.39 | 9,000 | 9,000 | |||||
| 2015-06-08 | 2015-06-05 | 4 | Fu Daotian | EPRS | Non-Employee Stock Option (Right to Buy) | D | 6.39 | 9,000 | 9,000 | |||||
| 2015-04-03 | 2015-04-02 | 4 | Wyand Michael | EPRS | Employee Stock Option (Right to Buy) | D | 8.40 | 20,000 | 20,000 | |||||
| 2015-03-02 | 2015-02-27 | 4 | Ticktin Robert | EPRS | Restricted Stock Units | D | 8,534 | 8,534 | ||||||
| 2015-03-02 | 2015-02-27 | 4 | Ticktin Robert | EPRS | Restricted Stock Units | D | 949 | 949 | ||||||
| 2015-03-02 | 2015-02-27 | 4 | Ticktin Robert | EPRS | Employee Stock Option (Right to Buy) | D | 10.53 | 65,006 | 65,006 | |||||
| 2015-03-02 | 2015-02-27 | 4 | Wyand Michael | EPRS | Restricted Stock Units | D | 10,432 | 10,432 | ||||||
| 2015-03-02 | 2015-02-27 | 4 | Wyand Michael | EPRS | Restricted Stock Units | D | 1,044 | 1,044 | ||||||
| 2015-03-02 | 2015-02-27 | 4 | Wyand Michael | EPRS | Employee Stock Option (Right to Buy) | D | 10.53 | 79,461 | 79,461 | |||||
| 2015-03-02 | 2015-02-27 | 4 | Shea Thomas A. | EPRS | Restricted Stock Units | D | 12,290 | 12,290 | ||||||
| 2015-03-02 | 2015-02-27 | 4 | Shea Thomas A. | EPRS | Restricted Stock Units | D | 1,044 | 1,044 | ||||||
| 2015-03-02 | 2015-02-27 | 4 | Shea Thomas A. | EPRS | Employee Stock Option (Right to Buy) | D | 10.53 | 93,609 | 93,609 | |||||
| 2015-03-02 | 2015-02-27 | 4 | Munshi Amit | EPRS | Restricted Stock Units | D | 39,548 | 39,548 | ||||||
| 2015-03-02 | 2015-02-27 | 4 | Munshi Amit | EPRS | Restricted Stock Units | D | 1,519 | 1,519 | ||||||
| 2015-03-02 | 2015-02-27 | 4 | Munshi Amit | EPRS | Employee Stock Option (Right to Buy) | D | 10.53 | 301,225 | 301,225 | |||||
| 2015-02-09 | 2015-02-06 | 4 | MONTREUX EQUITY PARTNERS IV LP | EPRS | Common Stock | D | 5.0093 | -100,000 | -501 | 1,671,400 | ||||
| 2015-02-09 | 2015-02-05 | 4 | MONTREUX EQUITY PARTNERS IV LP | EPRS | Common Stock | D | 4.9742 | -67,316 | -335 | 1,771,400 | ||||
| 2015-02-06 | 2015-02-04 | 4 | ROCKLAGE SCOTT M See Footnotes | EPRS | Common Stock | I | 5.0000 | 389,950 | 1,950 | 2,549,211 | ||||
| 2015-02-06 | 2015-02-04 | 4 | ROCKLAGE SCOTT M See Footnotes | EPRS | Common Stock | I | 5.0000 | 10,050 | 50 | 65,699 | ||||
| 2015-02-06 | 2015-02-04 | 4 | 5AM Partners III, LLC | EPRS | Common Stock | I | 5.0000 | 389,950 | 1,950 | 2,549,211 | ||||
| 2015-02-06 | 2015-02-04 | 4 | 5AM Partners III, LLC | EPRS | Common Stock | I | 5.0000 | 10,050 | 50 | 65,699 | ||||
| 2015-02-05 | 2015-02-04 | 4 | MONTREUX EQUITY PARTNERS IV LP | EPRS | Common Stock | D | 4.9505 | -5,684 | -28 | 1,838,716 | ||||
| 2015-02-05 | 2015-02-03 | 4 | MONTREUX EQUITY PARTNERS IV LP | EPRS | Common Stock | D | 4.9879 | -47,000 | -234 | 1,844,400 | ||||
| 2015-01-28 | 2015-01-26 | 4 | MONTREUX EQUITY PARTNERS IV LP | EPRS | Common Stock | D | 6.4675 | -38,516 | -249 | 1,891,400 | ||||
| 2015-01-26 | 2015-01-23 | 4 | MONTREUX EQUITY PARTNERS IV LP | EPRS | Common Stock | D | 6.2737 | -8,400 | -53 | 1,929,916 | ||||
| 2015-01-26 | 2015-01-22 | 4 | MONTREUX EQUITY PARTNERS IV LP | EPRS | Common Stock | D | 6.2972 | -14,130 | -89 | 1,938,316 | ||||
| 2014-09-03 | 3/A | ROCKLAGE SCOTT M | EPRS | Common Stock | I | 55,649 | ||||||||
| 2014-09-03 | 3/A | ROCKLAGE SCOTT M | EPRS | Common Stock | I | 2,159,261 | ||||||||
| 2014-08-04 | 3 | Livzon MABPharm Inc. | EPRS | Common Stock | D | 31,320,470 | ||||||||
| 2014-08-04 | 3 | Livzon MABPharm Inc. | EPRS | Common Stock | D | 31,320,470 | ||||||||
| 2014-07-25 | 3 | Montreux Equity Partners V, L.P. | EPRS | Common Stock | D | 24,953,987 | ||||||||
| 2014-07-25 | 3 | Montreux Equity Partners V, L.P. | EPRS | Common Stock | D | 41,763,682 | ||||||||
| 2014-07-25 | 3 | Montreux Equity Partners V, L.P. | EPRS | Common Stock | D | 24,953,987 | ||||||||
| 2014-07-25 | 3 | Montreux Equity Partners V, L.P. | EPRS | Common Stock | D | 41,763,682 | ||||||||
| 2014-07-25 | 3 | Montreux Equity Partners V, L.P. | EPRS | Common Stock | D | 24,953,987 | ||||||||
| 2014-07-25 | 3 | Montreux Equity Partners V, L.P. | EPRS | Common Stock | D | 41,763,682 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (2)(3) | EPRS | Common Stock | I | 4,374,171 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (2)(3) | EPRS | Common Stock | I | 4,374,171 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (1)(2) | EPRS | Common Stock | I | 2,270,559 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (1)(2) | EPRS | Common Stock | I | 2,270,559 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (2)(3) | EPRS | Common Stock | I | 4,374,171 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (1)(2) | EPRS | Common Stock | I | 2,270,559 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (1)(2) | EPRS | Common Stock | I | 2,270,559 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (2)(3) | EPRS | Common Stock | I | 4,374,171 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (1)(2) | EPRS | Common Stock | I | 2,270,559 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (1)(2) | EPRS | Common Stock | I | 2,270,559 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (2)(3) | EPRS | Common Stock | I | 4,374,171 | ||||||||
| 2014-07-25 | 3 | DIEKMAN JOHN D Footnote (2)(3) | EPRS | Common Stock | I | 4,374,171 | ||||||||
| 2014-07-17 | 2014-07-15 | 4 | BUCHI J KEVIN | EPRS | Non-Employee Stock Option (Right to Buy) | D | 1.30 | 13,259 | 13,259 | |||||
| 2014-07-17 | 2014-07-15 | 4 | CORRIGAN MARK | EPRS | Common Stock | D | 11.8000 | -14,597 | -172 | 21,859 | ||||
| 2014-07-17 | 2014-07-16 | 4 | Hunter William L | EPRS | Non-Employee Stock Option (Right to Buy) | D | 11.48 | 13,259 | 13,259 | |||||
| 2014-07-17 | 2014-07-16 | 4 | McHugh Julie | EPRS | Non-Employee Stock Option (Right to Buy) | D | 11.48 | 13,259 | 13,259 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Wyand Michael | EPRS | Employee Stock Option (Right to Buy) | D | 7.40 | 86,448 | 86,448 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Wyand Michael | EPRS | Employee Stock Option (Right to Buy) | D | 1.00 | 6,807 | 6,807 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Wyand Michael | EPRS | Employee Stock Option (Right to Buy) | D | 1.00 | 8,089 | 8,089 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Wyand Michael | EPRS | Employee Stock Option (Right to Buy) | D | 1.00 | 20,209 | 20,209 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Wyand Michael | EPRS | Common Stock | D | 21,641 | 21,641 | ||||||
| 2014-07-17 | 2014-07-15 | 4 | Shea Thomas A. | EPRS | Employee Stock Option (Right to Buy) | D | 7.40 | 93,608 | 93,608 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Shea Thomas A. | EPRS | Employee Stock Option (Right to Buy) | D | 1.30 | 49,588 | 49,588 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Munshi Amit | EPRS | Employee Stock Option (Right to Buy) | D | 7.40 | 332,694 | 332,694 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Munshi Amit | EPRS | Employee Stock Option (Right to Buy) | D | 1.00 | 37,541 | 37,541 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Munshi Amit | EPRS | Employee Stock Option (Right to Buy) | D | 1.00 | 25,885 | 25,885 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Munshi Amit | EPRS | Employee Stock Option (Right to Buy) | D | 1.00 | 64,670 | 64,670 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Munshi Amit | EPRS | Common Stock | D | 69,253 | 69,253 | ||||||
| 2014-07-17 | 2014-07-16 | 4 | Ticktin Robert | EPRS | Employee Stock Option (Right to Buy) | D | 11.48 | 99,442 | 99,442 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Seth Kim | EPRS | Employee Stock Option (Right to Buy) | D | 7.40 | 94,138 | 94,138 | |||||
| 2014-07-17 | 2014-07-15 | 4 | Seth Kim | EPRS | Employee Stock Option (Right to Buy) | D | 5.80 | 49,058 | 49,058 | |||||
| 2014-07-17 | 3 | COULTER JAMES G See Explanation of Responses | EPRS | No securities beneficially owned | I | 0 | ||||||||
| 2014-07-17 | 2014-07-15 | 4 | TPG Group Holdings (SBS) Advisors, Inc. See Explanation of Responses | EPRS | Common Stock | I | 22,239,223 | 22,239,223 | ||||||
| 2014-07-16 | 3 | DUYK GEOFFREY M | EPRS | No securities beneficially owned | D | 0 | ||||||||
| 2014-02-12 | 2014-02-10 | 4 | CORRIGAN MARK | ZLCS | Stock Option (Right to Buy) | D | 1.47 | 250,000 | 250,000 | |||||
| 2014-02-12 | 2014-02-10 | 4 | CORRIGAN MARK | ZLCS | Common Stock | D | 250,000 | 364,567 | ||||||
| 2014-02-12 | 2014-02-10 | 4 | Renz Justin A | ZLCS | Common Stock | D | 250,000 | 250,000 | ||||||
| 2014-01-17 | 2014-01-15 | 4 | CORRIGAN MARK | ZLCS | Common Stock | D | 1.6600 | -18,079 | -30 | 114,567 | ||||
| 2014-01-07 | 2014-01-03 | 4 | CORRIGAN MARK | ZLCS | Common Stock | D | 1.2200 | -8,035 | -10 | 132,646 | ||||
| 2013-06-10 | 2013-06-06 | 4 | CRAWFORD SALLY | ZLCS | Non-Qualified Stock Option (right to buy) | D | 0.58 | 15,000 | 15,000 | |||||
| 2013-06-10 | 2013-06-06 | 4 | HAYDU FRANK | ZLCS | Non-Qualified Stock Option (right to buy) | D | 0.58 | 15,000 | 15,000 | |||||
| 2013-06-10 | 2013-06-06 | 4 | OSHEA WILLIAM J | ZLCS | Non-Qualified Stock Option (right to buy) | D | 0.58 | 15,000 | 15,000 | |||||
| 2013-06-10 | 2013-06-06 | 4 | Kauffman Michael | ZLCS | Non-Qualified Stock Option (right to buy) | D | 0.58 | 15,000 | 15,000 | |||||
| 2013-06-10 | 2013-06-06 | 4 | Hunter William L | ZLCS | Non-Qualified Stock Option (right to buy) | D | 0.58 | 15,000 | 15,000 | |||||
| 2013-01-17 | 2013-01-15 | 4 | CORRIGAN MARK | ZLCS | Common Stock | D | 0.7700 | -112,850 | -87 | 844,090 | ||||
| 2013-01-07 | 2013-01-03 | 4 | CORRIGAN MARK | ZLCS | Stock Option (Right to Buy) | D | 0.76 | 500,000 | 500,000 | |||||
| 2013-01-07 | 2013-01-03 | 4 | CORRIGAN MARK | ZLCS | Common Stock | D | 250,000 | 956,940 | ||||||
| 2013-01-07 | 2013-01-03 | 4 | Cole Jason | ZLCS | Stock Option (Right to Buy) | D | 0.76 | 280,000 | 280,000 | |||||
| 2013-01-07 | 2013-01-03 | 4 | Renz Justin A | ZLCS | Stock Option (Right to Buy) | D | 0.76 | 280,000 | 280,000 | |||||
| 2012-05-25 | 2012-05-23 | 4 | CRAWFORD SALLY | ZLCS | Non-Qualified Stock Option (right to buy) | D | 0.76 | 15,000 | 15,000 | |||||
| 2012-05-25 | 2012-05-23 | 4 | HAYDU FRANK | ZLCS | Non-Qualified Stock Option (right to buy) | D | 0.76 | 15,000 | 15,000 | |||||
| 2012-05-25 | 2012-05-23 | 4 | OSHEA WILLIAM J | ZLCS | Non-Qualified Stock Option (right to buy) | D | 0.76 | 15,000 | 15,000 | |||||
| 2012-05-25 | 2012-05-23 | 4 | Kauffman Michael | ZLCS | Non-Qualified Stock Option (right to buy) | D | 0.76 | 15,000 | 15,000 | |||||
| 2012-05-25 | 2012-05-23 | 4 | Hunter William L | ZLCS | Non-Qualified Stock Option (right to buy) | D | 0.76 | 15,000 | 15,000 | |||||
| 2012-05-25 | 2012-05-23 | 4 | Foley Todd | ZLCS | Non-Qualified Stock Option (right to buy) | D | 0.76 | 15,000 | 15,000 | |||||
| 2012-02-29 | 2012-02-29 | 4 | Gallen Christopher C. | ZLCS | Common Stock | D | 350,000 | 1,842,986 | ||||||
| 2012-01-31 | 2012-01-27 | 4 | Cole Jason | ZLCS | Common Stock | D | 1.0900 | -2,420 | -3 | 15,086 | ||||
| 2012-01-27 | 2012-01-25 | 4 | CORRIGAN MARK | ZLCS | Non-Qualified Stock Option (right to buy) | D | 1.13 | 799,226 | 799,226 | |||||
| 2012-01-27 | 2012-01-25 | 4 | CORRIGAN MARK | ZLCS | Incentive Stock Option (right to buy) | D | 1.13 | 100,774 | 100,774 | |||||
| 2012-01-27 | 2012-01-25 | 4 | Cole Jason | ZLCS | Non-Qualified Stock Option (right to buy) | D | 1.13 | 242,809 | 242,809 | |||||
| 2012-01-27 | 2012-01-25 | 4 | Cole Jason | ZLCS | Incentive Stock Option (right to buy) | D | 1.13 | 107,191 | 107,191 | |||||
| 2012-01-27 | 2012-01-25 | 4 | Renz Justin A | ZLCS | Non-Qualified Stock Option (right to buy) | D | 1.13 | 313,121 | 313,121 | |||||
| 2012-01-27 | 2012-01-25 | 4 | Renz Justin A | ZLCS | Incentive Stock Option (right to buy) | D | 1.13 | 111,879 | 111,879 | |||||
| 2012-01-27 | 2012-01-25 | 4 | Gallen Christopher C. | ZLCS | Non-Qualified Stock Option (right to buy) | D | 1.13 | 53,692 | 53,692 | |||||
| 2012-01-27 | 2012-01-25 | 4 | Gallen Christopher C. | ZLCS | Incentive Stock Option (right to buy) | D | 1.13 | 271,308 | 271,308 | |||||
| 2012-01-19 | 2012-01-17 | 4 | CORRIGAN MARK | ZLCS | Common Stock | D | 1.1400 | -68,105 | -78 | 706,940 | ||||
| 2009-12-23 | 3 | Hunter William L | CRXX | Common Stock | D | 68,268 | ||||||||
| 2009-12-22 | 3 | Gallen Christopher C. | CRXX | Common Stock | D | 2,218,024 | ||||||||
| 2009-12-22 | 3 | Snutch Terrance P. | CRXX | Common Stock | D | 716,114 | ||||||||
| 2009-12-22 | 3 | Snutch Terrance P. By the Snutch Family Trust | CRXX | Common Stock | I | 53,982 | ||||||||
| 2009-12-22 | 3 | Wright C. Eugene | CRXX | No securities are beneficially owned. | D | 0 | ||||||||
| 2009-12-22 | 3 | CORRIGAN MARK | CRXX | Common Stock | D | 68,268 | ||||||||
| 2009-12-22 | 3 | Foley Todd | CRXX | Common Stock | D | 0 | ||||||||
| 2009-12-22 | 3 | Richardson Hartley T By James Richardson & Sons, Limited | CRXX | Common Stock | I | 9,564,403 | ||||||||
| 2009-12-22 | 3 | Richardson Hartley T | CRXX | Common Stock | D | 68,268 | ||||||||
| 2006-06-05 | 3 | Kauffman Michael | CRXX | None | D | 0 | ||||||||
| 2006-01-25 | 3 | Cole Jason | CRXX | No Securities Beneficially Owned | D | 0 | ||||||||
| 2005-11-17 | 2005-11-15 | 4 | Canaan Equity Partners II LLC | CRXX | Common Stock | I | 7.0000 | 259,349 | 1,815 | 259,349 | ||||
| 2005-11-17 | 2005-11-15 | 4 | Canaan Equity Partners II LLC | CRXX | Common Stock | I | 7.0000 | 907,653 | 6,354 | 907,653 | ||||
| 2005-11-17 | 2005-11-15 | 4 | Canaan Equity Partners II LLC | CRXX | Common Stock | I | 7.0000 | 706,352 | 4,944 | 706,352 | ||||
| 2005-11-17 | 2005-11-15 | 4 | YOUNG ERIC A | CRXX | Common Stock | I | 7.0000 | 259,349 | 1,815 | 259,349 | ||||
| 2005-11-17 | 2005-11-15 | 4 | YOUNG ERIC A | CRXX | Common Stock | I | 7.0000 | 907,653 | 6,354 | 907,653 | ||||
| 2005-11-17 | 2005-11-15 | 4 | YOUNG ERIC A | CRXX | Common Stock | I | 7.0000 | 706,352 | 4,944 | 706,352 | ||||
| 2005-11-09 | 3 | Lessem Jan | CRXX | Common Stock, $0.001 par value | D | 36,714 | ||||||||
| 2005-11-09 | 3 | Lessem Jan Footnote | CRXX | Common Stock, $0.001 par value | I | 1,143 | ||||||||
| 2005-11-09 | 3 | Keith Curtis T | CRXX | Common Stock, $0.001 par value | D | 42,857 | ||||||||
| 2005-11-09 | 3 | Goldfield Jacob | CRXX | Common Stock, $0.001 par value | D | 2,857 | ||||||||
| 2005-11-09 | 3 | Goldfield Jacob | CRXX | Common Stock, $0.001 par value | D | 2,857 | ||||||||
| 2005-11-09 | 3 | Borisy Alexis | CRXX | Common Stock, $0.001 par value | D | 271,429 |
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
